Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR-γ Signaling Pathway
Diabetes & Metabolism Journal · 31.07.2024 · 48 (4) · 716-729
DOI: 10.4093/dmj.2023.0031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 31.07.2024. Verfasst von Shan-Shan Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi,…. Hauptthemen laut MEDLINE: Myocardium, Signal Transduction, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Top Talent Support Program for young and middle-aged people of Wuxi Health Committee.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes-induced cardiac fibrosis is one of the main mechanisms of diabetic cardiomyopathy. As a common histone methyltransferase, enhancer of zeste homolog 2 (EZH2) has been implicated in fibrosis progression in multiple organs. However, the mechanism of EZH2 in diabetic myocardial fibrosis has not been clarified.
Methods
In the current study, rat and mouse diabetic model were established, the left ventricular function of rat and mouse were evaluated by echocardiography and the fibrosis of rat ventricle was evaluated by Masson staining. Primary rat ventricular fibroblasts were cultured and stimulated with high glucose (HG) in vitro. The expression of histone H3 lysine 27 (H3K27) trimethylation, EZH2, and myocardial fibrosis proteins were assayed.
Results
In STZ-induced diabetic ventricular tissues and HG-induced primary ventricular fibroblasts in vitro, H3K27 trimethylation was increased and the phosphorylation of EZH2 was reduced. Inhibition of EZH2 with GSK126 suppressed the activation, differentiation, and migration of cardiac fibroblasts as well as the overexpression of the fibrotic proteins induced by HG. Mechanical study demonstrated that HG reduced phosphorylation of EZH2 on Thr311 by inactivating AMP-activated protein kinase (AMPK), which transcriptionally inhibited peroxisome proliferator-activated receptor γ (PPAR-γ) expression to promote the fibroblasts activation and differentiation.
Conclusion
Our data revealed an AMPK/EZH2/PPAR-γ signal pathway is involved in HG-induced cardiac fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Top Talent Support Program for young and middle-aged people of Wuxi Health Committee
- Wuxi Translational Medicine Center
Zitieren
APA
Li, S. S., Pan, L., Zhang, Z. Y., Zhou, M. D., Chen, X. F., Qian, L. L., Dai, M., Lu, J., Yu, Z. M., Dang, S., & Wang, R. X. (2024). Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR-γ Signaling Pathway. Diabetes & Metabolism Journal, 48(4), 716-729. https://doi.org/10.4093/dmj.2023.0031
Vancouver
Li SS, Pan L, Zhang ZY, Zhou MD, Chen XF, Qian LL, et al. Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR-γ Signaling Pathway. Diabetes & Metabolism Journal. 2024;48(4):716-729. doi:10.4093/dmj.2023.0031
BibTeX
@article{Li2024,
author = {Li, Shan-Shan and Pan, Lu and Zhang, Zhen-Ye and Zhou, Meng-Dan and Chen, Xu-Fei and Qian, Ling-Ling and Dai, Min and Lu, Juan and Yu, Zhi-Ming and Dang, Shipeng and Wang, Ru-Xing},
title = {Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR-γ Signaling Pathway},
journal = {Diabetes & Metabolism Journal},
year = {2024},
volume = {48},
number = {4},
pages = {716--729},
doi = {10.4093/dmj.2023.0031}
}
EUVIMED